Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

40 results about "Genetically modified organism" patented technology

A genetically modified organism (GMO) is any organism whose genetic material has been altered using genetic engineering techniques. The exact definition of a genetically modified organism and what constitutes genetic engineering varies, with the most common being an organism altered in a way that "does not occur naturally by mating and/or natural recombination". A wide variety of organisms have been genetically modified (GM), from animals to plants and microorganisms. Genes have been transferred within the same species, across species (creating transgenic organisms) and even across kingdoms. New genes can be introduced, or endogenous genes can be enhanced, altered or knocked out.

Cytosine deaminase and use thereof in base editing

The present invention relates to the field of genetic engineering. Specifically, the present invention relates to cytosine deaminase and use thereof in base editing. More specifically, the present invention relates to a base editing system based on a newly identified cytosine deaminase, a method for base editing a target sequence in the genome of an organism (e.g., a plant) using the base editing system, and a genetically modified organism (e.g., a plant) produced by the method and progenies thereof.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

Cytosine deaminases and their use in base editing

The invention relates to the field of gene engineering. In particular, the present invention relates to cytosine deaminases and their use in base editing. More specifically, the invention relates to a method for screening and identifying a deaminase, a base editing system based on a newly identified cytosine deaminase, a method for editing a target sequence in a genome of an organism (such as a plant) by using the base editing system, and a method for screening and identifying the target sequence. As well as genetically modified organisms (e.g., plants) and progeny thereof produced by the method.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

Application of SmCLE mature peptide in inhibiting plant aging

The invention discloses application of SmCLE mature peptide in inhibiting plant aging, and belongs to the technical field of plant biology. The invention discloses application of a SmCLE mature peptide in inhibiting plant aging. The amino acid sequence of the SmCLE mature peptide is SEQ ID NO: 1. The CLE peptide is applied to the aspect of inhibiting plant aging, solves the problem that the existing CLE peptide cannot be applied to anti-aging of plants, especially medicinal plants or non-mode crops, has the advantages of small molecular weight, easiness in synthesis, low action concentration and good biocompatibility, can realize accurate regulation and control of leaf aging through exogenous application, and has a wide application prospect. And the safety problem of transgenic organisms is avoided.
Owner:HEBEI UNIV OF ENG

Crispr-cas nickase system-based precise genome editing method

The present invention relates to a CRISPR-Cas nickase system-based precise genome editing method. The genome editing method of the present invention can improve the precision of genome editing by reducing off-target effects, and thus can be effectively used in various fields such as new drug development, genetic disease treatment, genetically modified organism (GMO) development, and production of model animals used for organ transplantation.
Owner:CHUNG ANG UNIV IND ACADEMIC COOP FOUND

Application of ScGAME9 gene in improving cold resistance of potato

The present invention relates to the field of biotechnology, specifically to ScGAME9 The invention discloses a gene for regulating the cold resistance of potatoes. ScGAME9 A gene, the nucleotide sequence of which is as shown in (a), (b) or (c), (a) the nucleotide sequence shown in SEQ ID NO.2; (b) a nucleotide sequence that hybridizes with and encodes the nucleotide sequence shown in SEQ ID NO.2; (c) a nucleotide sequence that has more than 80% homology with the nucleotide sequence shown in SEQ ID NO.2 and encodes. ScGAME9 Or its transgenic biological materials can regulate the cold tolerance of potato plants, providing important theoretical support for the screening of genetically transformed positive plants and the study of the mechanism of potato resistance to low temperature stress, and have broad application prospects.
Owner:YUNNAN NORMAL UNIV

Genetically modified organisms for producing psychotropic alkaloids

This disclosure provides genetically engineered organisms with genetic modifications that are useful for producing desirable alkaloids. This disclosure also provides methods of making genetically engineered organisms that can produce desirable alkaloids. The organisms described herein produce alkaloids in amounts beyond that produced from comparable wild-type organisms. In certain embodiments, the genetically engineered organisms are fungi from the Basidiomycota division.
Owner:INTIMA BIOSCIENCE INC

Monbretin A (MbA) synthesis using a heterologous nucleic acid(s) encoding A MbA pathway enzyme

Provided are transgenic organisms, such as plants and plant parts, cells, and related compositions and methods for producing and monitoring the genotype for enhanced production of montbretin A and / or its precursors. For example, provided is a transgenic organism comprising at least one heterologous nucleic acid operatively linked to a promoter, wherein the heterologous nucleic acid encodes at least one enzyme in a montbretin A (MbA) metabolic pathway. The organisms can be a plant, plant part, or plant cell, or a microorganism such as a yeast. Also provided is a method for producing at least one montbretin A (MbA) precursor and / or MbA, comprising permitting the expression of the at least one heterologous nucleic acid in the transgenic organism. The disclosure also provides isolated nucleic acid molecules that comprise sequence encoding at least one enzyme in a montbretin A (MbA) metabolic pathway and vectors comprising the nucleic acids.
Owner:THE UNIV OF BRITISH COLUMBIA

Depolymerization of a polyhydroxyalkanoate and recycling of hydroxyalkonoate monomer obtained thereby via a metabolic process

A process is disclosed for production of a polyhydroxyalkanoate that includes depolymerization of a post-consumer polyhydroxyalkanoate and utilization of the hydroxyalkanoate monomer thus produced as a carbon source for a microorganism capable of production of a polyhydroxyalkanoate. Methods can be utilized for true cyclic use of polyhydroxyalkanoates including polyhydroxybutyrates. Various aspects are described including simultaneous depolymerization and polymer production, utilization of purified depolymerase enzymes and / or microorganisms that express a depolymerase in conjunction with a microorganism that produces polymer, utilization of microorganisms that produce both a depolymerase and a new polymer, and utilization of genetically modified organisms to produce natural or modified depolymerase enzymes.
Owner:KIMBERLY CLARK WORLDWIDE INC

Method of mapping transgene integration

Provided is a computer implemented method for mapping transgene integration into n organism by providing a custom genome comprising a reference genome sequence and a transgene sequence, aligning sequence reads of the transgenic organism to the custom genome, identifying candidate junction reads, wherein the candidate junction reads correspond to sequence reads comprising sequence regions that align to the transgene sequence and to the host sequence, categorizing the candidate junction reads into junction clusters, wherein each of the junction clusters comprises a plurality of the candidate junction reads each with an alignment segment terminus within a cluster proximity region of the custom genome, determining a transgene junction based on the junction clusters that possesses at least three of the candidate junction reads within the cluster proximity region of the custom genome and mapping the integration of the transgene into the transgenic organism based on the transgene junctions.
Owner:TACONIC BIOSCIENCES INC

Method for evaluating defoliating insect resistance of insect-resistant transgenic poplar in field environment and application of defoliating insect resistance of insect-resistant transgenic poplar in field environment

The invention relates to a defoliating pest resistance evaluation method for insect-resistant transgenic poplar in a field environment and application, and belongs to the technical field of transgenic poplar breeding and environmental safety evaluation. According to the method, insect-resistant transgenic poplar and non-transgenic poplar are used as materials, a three-level classification standard based on damage area proportion is established through an orientation equilibrium sampling method by utilizing environmental monitoring and leaf damage detection, and fine evaluation of the defoliating insect resistance of the insect-resistant transgenic poplar is further realized. Field defoliating pest resistance evaluation is an important part of insect-resistant transgenic organism safety evaluation, and it is proved that insect-resistant transgenic poplars have good defoliating pest resistance. Through standardized sampling, high-precision detection and a scientific grading system, the problems of insufficient sample representativeness, inaccurate damage quantification and unscientific grading standard of an existing method for evaluating the field defoliating pest resistance of the transgenic insect-resistant poplar are solved, and a reliable basis is provided for biological safety evaluation and insect-resistant variety breeding of the transgenic poplar.
Owner:INST OF FORESTRY CHINESE ACAD OF FORESTRY

Method for detecting transgenic plant based on VTD-CRISPR technology

Along with wide planting of transgenic crops, many countries start to carry out quantitative identification on transgenic products, but the prior art still faces huge challenges in the aspect of absolute quantitative detection, so that the invention provides a vortex-driven droplet digital CRISPR / Cas (VTD-CRISPR) detection method, and belongs to the field of nucleic acid detection. According to the invention, experimental parameters of the VTD-CRISPR technology are systematically optimized, so that the reliability and the accuracy of a detection result are ensured to the greatest extent; next, the detection specificity and sensitivity of the VTD-CRISPR are further verified by comparison with the commercially used qPCR and ddPCR technologies. In addition, the invention also explores the possibility that manual operation replaces vortex to generate liquid drops and is combined with a CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology. In conclusion, the VTD-CRISPR technology has an excellent qualitative function and an absolute quantitative function, and compared with other technologies, the VTD-CRISPR technology has the advantages of shorter detection time and lower cost, so that the VTD-CRISPR technology has great potential in practical application of quantitative detection of transgenic organisms.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES +1

Method for preparing fish skin collagen peptide with high antioxidant and anti-inflammatory activity by utilizing fermentation of Burkholderia sp.S3-7

The invention relates to a Burkholderia sp.S3-7 strain, which is characterized in that the Burkholderia sp.S3-7 strain is preserved in Guangdong Microbial Culture Collection Center on July 15, 2025, the preservation number is GDMCC NO.66685, and the preservation address is the 5th floor, No. 59 building, No. 100 Courtyard, Xianlie Middle Road, Guangzhou. The Burkholderia sp.S3-7 provided by the invention has relatively high degradation capacity and safety on collagen, can remarkably improve the yield of fish skin collagen peptide, does not have safety risks possibly brought by transgenic organisms, is high in public acceptability, is more suitable for being applied to the fields of food, health care products and the like, ensures the safety of the product and widens the application range of the product.
Owner:GUANGZHOU JINAN BIOMEDICINE RES & DEV CENT

Enzymes and microbes for xanthan gum processing

The present disclosure provides polypeptides having xanthan lyase activity, compositions, and uses thereof. The present disclosure also provides polynucleotides, expression vectors, host cells, and genetically modified organisms (e.g., bacteria) encoding xanthan lyases.
Owner:THE RGT UNIV OF MICHIGAN

RNA-only, positive control target for clinical diagnostic testing

A control strategy for RNA-based bacterial nucleic acid amplification tests (NAATs), such as reverse transcription PCR (RT-PCR) and reverse transcription loop-mediated isothermal amplification (RT-LAMP), that allows ready discrimination of RNA from DNA templates using self-splicing bacterial introns, such that those nucleic acids ultimately encode different sequences. Described are two exemplary vectors encoding synthetic transgenes based on this principle, one that is active in the gram-negative bacterium Escherichia coli and one that functions in both E. coli and the gram-positive organism Staphylococcus aureus. Using multiplexed fluorescent RT-LAMP of heat-lysed specimens, the practicality of deploying such transgenic organisms as an internal control to ascertain sample integrity and assay performance during clinical diagnostic testing is demonstrated. The approach has broad utility for RNA-based bacterial nucleic acid amplification tests, especially point-of-care assays and other applications where nucleic acids are nonspecifically liberated for testing.
Owner:UNIV OF WASHINGTON

Expression cartridge for the transformation of eukaryotic cells, method for transforming eukaryotic cells, genetically modified organism, method for producing biofuels and / or biochemicals, and thus produced biofuel

The present invention describes the expression cassette for transforming eukaryotic cell which comprises the peptide encoding non-natural sequence of nucleotides with xylose isomerase feature (SEQ ID NO: 1), optionally also comprising other genes of pentose phosphate route. Additionally, it is described the microorganism filed under the number DSM28739, which, in addition to the above-mentioned modifications, also present genetic modifications from adaptive evolution. The described microorganism shows efficient consumption of xylose and conversion of ethanol when compared to its correspondent without said genetic modifications and mutations from evolution. It is also described the process for producing biofuels e biochemicals, preferably ethanol, mainly from the lignocellulosic portion of the vegetal biomass. Biofuels, preferably ethanol, and biochemicals produced by the process of the invention are also described.
Owner:BIOFLEX AGROINDUSTRIAL SA

Depolymerization of a Polyhydroxyalkanoate and Recycling of Hydroxyalkonoate Monomer Obtained Thereby Via a Metabolic Process

A process is disclosed for production of a polyhydroxyalkanoate that includes depolymerization of a post-consumer polyhydroxyalkanoate and utilization of the hydroxyalkanoate monomer thus produced as a carbon source for a microorganism capable of production of a polyhydroxyalkanoate. Methods can be utilized for true cyclic use of polyhydroxyalkanoates including polyhydroxybutyrates. Various aspects are described including simultaneous depolymerization and polymer production, utilization of purified depolymerase enzymes and / or microorganisms that express a depolymerase in conjunction with a microorganism that produces polymer, utilization of microorganisms that produce both a depolymerase and a new polymer, and utilization of genetically modified organisms to produce natural or modified depolymerase enzymes.
Owner:KIMBERLY CLARK WORLDWIDE INC

A hybridoma cell line, its produced antibodies, and their applications

This invention discloses a hybridoma cell line containing the herbicide-resistant protein GAT, its produced antibody, and its applications. The hybridoma cell line is deposited at the China General Microbiological Culture Collection Center (CGMCC), accession number CGMCC No. 46332. The preparation method includes: a) purifying prokaryotic expression to obtain recombinant GAT protein; b) immunizing animals: using the recombinant GAT protein as an antigen to immunize BALB / c mice; c) cell fusion: collecting spleen cells from immunized BALB / c mice and fusing them with SP2 / 0 cells; d) cell line establishment: subcloning using the limiting dilution method, performing ELISA detection on subclones after 5-7 days, until a stable hybridoma cell line secreting positive antibodies is selected for expansion, reculturing, and preservation. The monoclonal antibody secreted by the hybridoma cell line of this invention lays the foundation for the detection of the herbicide-resistant protein GAT in transgenic crops, thus supporting the development of transgenic crops. street The development, seed production, and preservation of genetically modified crops have ensured the survival of genetically modified organisms (GMOs). street The industrialization of genetically modified crops is progressing steadily, and the sustainable application of related transformants is advancing.
Owner:THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI

Cytosine deaminases and their use in base editing

This invention relates to the field of genetic engineering. Specifically, it relates to cytosine deaminases and their use in base editing. More specifically, it relates to a method for screening and identifying deaminases, a base editing system based on newly identified cytosine deaminases, a method for base editing a target sequence in the genome of an organism (e.g., a plant) using this base editing system, and genetically modified organisms (e.g., plants) and their offspring produced by said method.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

Method for evaluating influence of transgenic crops on soil microflora

The invention belongs to the technical field of safety evaluation of soil microbiology and transgenic organisms, and particularly relates to a method for evaluating the influence of transgenic crops on soil microbial communities. According to the method, rhizosphere and rhizosphere soil samples before planting, in different growth periods and after harvesting of transgenic crops are collected, and the influence of the transgenic crops and non-transgenic control crops on soil microbial communities is evaluated through the steps of pretreatment, microbial culture, statistical analysis and the like. The method is suitable for a variety of crops, and is also suitable for comparative analysis of the influence of herbicide spraying on herbicide-resistant transgenic crop soil microflora. The method provides an efficient, simple, convenient and economical evaluation scheme for ecological safety evaluation of the transgenic crops, and has important significance for promoting sustainable utilization of the transgenic crops.
Owner:INST OF COTTON RES CHINESE ACAD OF AGRI SCI

Biosynthesis of hue-tunable indigo dyes

A biosynthetic method and composition for producing indigo dyes comprising indigotin and isatin. A tryptophanase (TRP) and a flavin monooxygenase (FMO) can be produced through a transgenic organism having carrier encoded tryptophanase and flavin monooxygenase. The produced tryptophanase and flavin monooxygenase convert L-tryptophan into indigo dyes in the presence of one or more bioactive additives selected from cysteine, 2-hydroxyindole, or 2-indoxyl, and the weight ratio of indigotin to isatin in the dyes is between 1:0.1 to 1:4. The dyes have a hue of X: 0.1920 to 0.2481, Y: 0.2537 to 0.2019, Z: 0.5543 to 0.5501 in the CIE XYZ color space definition. Selectable and repeatable dyeing hues are provided.
Owner:NANO & ADVANCED MATERIALS INST

Anti-fentanyl antibodies

The present invention concerns the field of antibodies. More specifically, it relates to an antibody which specifically binds to a hapten being fentanyl or a derivative thereof, said antibody binding to the hapten with an equilibrium dissociation constant (Kd) of at most 1.000 pM, at most 800 pM, at most 600 pM, at most 400 pM, at most 200 pM, at most 100 pM or at most 75 pM, wherein the binding pocket for the hapten comprises amino acids from all three complementary determining regions (CDRs) of each chain. The present invention also relates to a polynucleotide encoding said antibody, a vector or expression construct comprising the poly-nucleotide, a host cell comprising the polynucleotide or the vector or expression construct or a non-human transgenic organism comprising said polynucleotide or said vector or expression construct. The invention also relates to said antibody or said polynucleotide for use as a medicament for treating and / or preventing a disease or condition in a subject associated with administration fentanyl or a derivative thereof.
Owner:DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS +1

Waste disposal systems in genetically modified organisms

This invention provides a waste treatment system that improves the efficiency of operating energy when processing materials, including genetically modified organisms. [Solution] The system comprises a manufacturing unit 10 that produces a target substance from raw plant material, an energy supply facility 50 that supplies manufacturing energy to the manufacturing unit 10, an inactivation device 20 into which a primary material A containing genetically modified organisms, etc., discharged as residue from the manufacturing unit 10 is introduced and the primary material A is heated at a first temperature to process it into a secondary material B in which the genetically modified organisms, etc., are inactivated, a methane fermentation device 30 which is a volume reduction device into which the secondary material B is introduced and the secondary material B is heated at a second temperature lower than the first temperature to reduce the volume of the secondary material B, a first pipe 61 that introduces the primary material A from the manufacturing unit 10 to the inactivation device 20, a second pipe 62 that introduces the secondary material B from the inactivation device 20 to the methane fermentation device 30, and a heat exchanger 40 located in the middle of the first pipe 61 and the second pipe 62.
Owner:KAJIMA CORP

Fusion protein of Z-domain and calcein with improved reactivity, stability and antibody recovery rate and method for separating and purifying antibodies using the same

The present invention relates to a fusion protein of a Z-domain and calcitonin with improved reactivity, stability and antibody recovery, and a method for separating and purifying antibodies using the same. Specifically, the present invention relates to a nucleic acid encoding a fusion protein of a Z-domain and calcitonin with improved reactivity and stability, a recombinant expression vector comprising the nucleic acid, a transgenic organism transformed by the recombinant expression vector, and a method for separating and purifying antibodies using the Z-domain and calcitonin fusion protein with improved reactivity, stability, antibody recovery and purity.
Owner:KOREA INST OF CERAMIC ENG & TECH

METHOD FOR PRODUCING POTATO PLANT WITH SUPPRESSED BROWNING USING CRISPR / Cas9 SYSTEM

A method for producing a potato plant with suppressed browning may use CRISPR / Cas9 system. In a method of producing a genome-edited potato plant with suppressed browning, a potato protoplast is transfected with a ribonucleoprotein complex containing sgRNA which targets StPPO2 (Solanum tuberosum Polyphenol Oxidase 2) gene derived from potato. Since the method involves no insertion of a foreign gene and includes only tiny mutation that is hardly distinguishable from natural mutation, it is expected that, unlike genetically modified organism (GMO) crops which require a huge amount of cost and time for evaluating the safety and negative environmental impacts, a great deal of cost and time can be saved in the present invention.
Owner:TOOLGEN INC

Glucose tolerance beverages and methods of use

Aspects described herein relate to a glucose tolerance beverage composition comprising, consisting of, or consisting essentially of: a) 50 g, 75 g, or 100 g dextrose from a non-GMO source; b) organic peppermint leaf; and c) organic or crystalized lemon; wherein the beverage composition is free of or substantially free of protein or DNA from GMOs, Brominated Vegetable Oil (BVO), Bisphenol A (BPA), animal and / or dairy products, gluten, or artificial additives, preservatives, flavors, or colors, and wherein the glucose tolerance test beverage composition has a variance threshold of no more than 5%. In various embodiments, the beverage composition is formulated as a soluble powder or a ready-to-drink beverage, particularly a pre-mixed 10 oz. beverage. Methods are also provided for using the beverage composition to perform one-step or two-step oral glucose tolerance tests for gestational diabetes mellitus.
Owner:BERG JACQUELINE

ABCG-type sorgoleone transporter from sorghum bicolor

PCT designated stageWO2025184293A1BiocidePlant peptidesBiotechnologySorgoleone
The present disclosure provides for the use of a sorgoleone transporter protein, originally from Sorghum bicolor, in transgenic organisms and cells, such as plants or plant cells. This transporter protein can be incorporated into any plant desired, either alone, or in combination with enzymes of the sorgoleone biosynthesis pathway. Thus, sorgoleone-producing plants and other cells can be constructed.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES +2

Enzymes for luciferin biosynthesis and their use

This invention provides enzymes that promote the stable and / or intracellularly abundant synthesis of luciferin from precursor compounds, and the reduction of oxyluciferin to luciferin, as well as uses thereof. [Solution] A method for preparing compounds identical to fungal luciferin and preluciferin in vitro or in vivo is provided; an expression cassette comprising nucleic acids, vectors, and regulatory elements necessary for nucleic acid expression in selected host cells; further, a combination of nucleic acids for obtaining cells, stable cell lines, transgenic organisms (e.g., plants, animals, fungi, or microorganisms), autoluminescent cells, cell lines, or transgenic organisms containing nucleic acids, vectors, or expression cassettes; a combination of proteins for producing luciferin or its precursors from simpler compounds; and a kit comprising nucleic acids, vectors, or expression cassettes for producing luminescent cells, cell lines, or transgenic organisms.
Owner:LIGHT BIO INC